194 related articles for article (PubMed ID: 15101565)
1. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
Robison LM; Sclar DA; Skaer TL; Galin RS
Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
[TBL] [Abstract][Full Text] [Related]
2. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.
Robison LM; Skaer TL; Sclar DA; Galin RS
CNS Drugs; 2002; 16(2):129-37. PubMed ID: 11825103
[TBL] [Abstract][Full Text] [Related]
3. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
Albert M; Rui P; Ashman JJ
NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
[TBL] [Abstract][Full Text] [Related]
4. Medication management of stimulants in pediatric practice settings: a national perspective.
Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS
J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959
[TBL] [Abstract][Full Text] [Related]
5. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
[TBL] [Abstract][Full Text] [Related]
6. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.
Robison LM; Sclar DA; Skaer TL; Galin RS
Clin Pediatr (Phila); 1999 Apr; 38(4):209-17. PubMed ID: 10326176
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
8. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.
Arch Gen Psychiatry; 1999 Dec; 56(12):1088-96. PubMed ID: 10591284
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003.
Sankaranarayanan J; Puumala SE; Kratochvil CJ
Curr Med Res Opin; 2006 Aug; 22(8):1475-91. PubMed ID: 16870073
[TBL] [Abstract][Full Text] [Related]
10. National trends in the treatment of attention deficit hyperactivity disorder.
Olfson M; Gameroff MJ; Marcus SC; Jensen PS
Am J Psychiatry; 2003 Jun; 160(6):1071-7. PubMed ID: 12777264
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
[No Abstract] [Full Text] [Related]
13. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
15. Treatment with stimulants among youths in a large California health plan.
Habel LA; Schaefer CA; Levine P; Bhat AK; Elliott G
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):62-7. PubMed ID: 15741787
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
Davis DW; Feygin Y; Creel L; Williams PG; Lohr WD; Jones VF; Le J; Pasquenza N; Ghosal S; Jawad K; Yan X; Liu G; McKinley S
J Pediatr; 2019 Apr; 207():185-191.e1. PubMed ID: 30545564
[TBL] [Abstract][Full Text] [Related]
17. Treatment of US Children With Attention-Deficit/Hyperactivity Disorder in the Adolescent Brain Cognitive Development Study.
Olfson M; Wall MM; Wang S; Laje G; Blanco C
JAMA Netw Open; 2023 Apr; 6(4):e2310999. PubMed ID: 37115542
[TBL] [Abstract][Full Text] [Related]
18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
19. Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program.
Zima BT; Bussing R; Tang L; Zhang L; Ettner S; Belin TR; Wells KB
J Am Acad Child Adolesc Psychiatry; 2010 Dec; 49(12):1225-37, 1237.e1-11. PubMed ID: 21093772
[TBL] [Abstract][Full Text] [Related]
20. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
Rohatgi RK; Bos JM; Ackerman MJ
Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
